- Home
- LANC vs STIM Comparison
LANC vs STIM Comparison
Compare LANC & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LANC
- STIM
- Stock Information
- Founded
- LANC 1961
- STIM 2003
- Country
- LANC United States
- STIM United States
- Employees
- LANC N/A
- STIM N/A
- Industry
- LANC Packaged Foods
- STIM Medical/Dental Instruments
- Sector
- LANC Consumer Staples
- STIM Health Care
- Exchange
- LANC Nasdaq
- STIM Nasdaq
- Market Cap
- LANC N/A
- STIM 232.3M
- IPO Year
- LANC N/A
- STIM 2018
- Fundamental
- Price
- LANC $165.41
- STIM $4.65
- Analyst Decision
- LANC Buy
- STIM Buy
- Analyst Count
- LANC 4
- STIM 4
- Target Price
- LANC $209.67
- STIM $6.00
- AVG Volume (30 Days)
- LANC 222.8K
- STIM 818.1K
- Earning Date
- LANC 04-30-2025
- STIM 05-06-2025
- Dividend Yield
- LANC 2.30%
- STIM N/A
- EPS Growth
- LANC 27.36
- STIM N/A
- EPS
- LANC 6.15
- STIM N/A
- Revenue
- LANC $1,886,520,000.00
- STIM $89,448,000.00
- Revenue This Year
- LANC $5.03
- STIM $102.36
- Revenue Next Year
- LANC $3.31
- STIM $9.83
- P/E Ratio
- LANC $26.87
- STIM N/A
- Revenue Growth
- LANC 0.69
- STIM 22.16
- 52 Week Low
- LANC $156.14
- STIM $0.52
- 52 Week High
- LANC $202.63
- STIM $5.92
- Technical
- Relative Strength Index (RSI)
- LANC 38.25
- STIM 62.92
- Support Level
- LANC $158.84
- STIM $3.30
- Resistance Level
- LANC $163.49
- STIM $4.64
- Average True Range (ATR)
- LANC 4.76
- STIM 0.33
- MACD
- LANC -2.64
- STIM 0.05
- Stochastic Oscillator
- LANC 24.88
- STIM 89.11
About STIM Neuronetics Inc.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.